CUBIST PHARMACEUTCL (NASDAQ:CBST)
16.95
0.1 (0.59%)
| CUBIST PHARMACEUTCL (NASDAQ:CBST) Delayed : | |||||
|---|---|---|---|---|---|
| Previous Close | $17.05 | 52 Week High | $28.74 | ||
| Open | $17.03 | 52 Week Low | $13.81 | ||
| Day High | $17.22 | P/E | 6.14 | ||
| Day Low | $16.85 | EPS | $2.76 | ||
| Volume | 1,044,573 | ||||
| More CBST Info: Chart SEC Filings Profile Historical Options | |||||
What is this?Friends, Peers and Foes
| Ticker | # Stories | Ticker | # Stories |
|---|---|---|---|
| TPX | 5 | GOOG | 5 |
| COF | 4 | AMD | 4 |
| MSCC | 3 | COF | 3 |
| EZPW | 3 | AMD | 3 |
| SCSC | 3 | MSCC | 2 |
| WFR | 2 | NVS | 2 |
Entities who have mentioned CBST
- Trading Radar | View Related Stories »
- Needham & Co | View Related Stories »
- Standard & Poor's | View Related Stories »
- UBS | View Related Stories »
- Dividend | View Related Stories »
- Initial Jobless Claims | View Related Stories »
- Robert W Baird | View Related Stories »
- Susquehanna International Group of Companies | View Related Stories »
- Citi | View Related Stories »
- RBC Capital | View Related Stories »
- StreetInsider.com Morning Movers | View Related Stories »
- BB&T Capital Markets | View Related Stories »
- Crude Oil | View Related Stories »
- After-Hours Movers | View Related Stories »
- Barclays | View Related Stories »
- Jefferies & Co | View Related Stories »
- Soleil Securities | View Related Stories »
- Thomas Weisel Partners Group | View Related Stories »
- Notable Calls | View Related Stories »
- Merrill Lynch | View Related Stories »
- Calyon Securities | View Related Stories »
- Banc of America | View Related Stories »
- Unusual 11 Mid-Day Movers | View Related Stories »
- Layoffs | View Related Stories »
- ThinkEquity | View Related Stories »
View All Major News StreetInsider.com Major News for CBST
- Cubist Pharmaceuticals (CBST) Tops Q3 EPS Views
- Cubist Pharma (CBST) Reports Mixed Q2 Results
- Cubist Pharma (CBST) Reports Q1 EPS of $0.13, Beats by 3c
View All ReportsStreetInsider.com Reports on CBST
- Oppenheimer Upgrades Cubist Pharmaceuticals (CBST) to Perform
- Cubist Pharmaceuticals (CBST) Tops Q3 EPS Views
- Baird Downgraded Cubist Pharmaceuticals (CBST) and Cephalon (CEPH) to Neutral On Challenging Growth
- Cubist Pharmaceuticals (CBST) Up On Takeover Chatter
- Cubist Pharmaceuticals (CBST) September volatility at 52
View All Press ReleasesCompany Press Releases on CBST
- The Boston Globe names Cubist to Globe 100's Top Places to Work '09
- Cubist Pharmaceuticals to Present at Lazard Capital Markets 6th Annual Healthcare Conference
- Hydra Biosciences and Cubist Form Collaboration to Develop Novel Ion Channel Drugs for Pain Management
- Cubist Pharmaceuticals 3rd Quarter Total Net Revenues Up 28%
- Cubist Pharmaceuticals Announces Third Quarter 2009 Earnings Call
StreetInsider Reports on CBST by Category
View All BlogsBlogs on CBST
- Biotech Stocks for a Possible Year-End Rally
- What We Like About Cubist Pharma
- Cubist Pharmaceuticals, Inc. Q3 2009 Earnings Call Transcript
- Biotech: Q3 Market Update
- Thursday Options Update: BRCD, WYN, CAR, TGT, CBST & KMB
View All FilingsSEC Filings on CBST
- Form 10-Q CUBIST PHARMACEUTICALS For: Sep 30
- Form 8-K CUBIST PHARMACEUTICALS For: Oct 15
- Form 4 Vetticaden Santosh For: Sep 30
- Form 4 GILMAN STEVEN C For: Sep 30
Comments on recent CBST articles
Comments on CBST
No comments are currently available.
on Dec 8, 2008
at 02:24 PM Genworth There is news driving the price change. State ins. regulators meeting in Tx. have agreed to lower Capital funding requirements. Do your homework before posting info.
Article: Unusual 11 Mid-Day Movers 12/08: GNW, DRYS, PLD, TBSI Higher; ALTH, LSI, CBST, HL Lower